Publication | Open Access
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients
34
Citations
13
References
2018
Year
Hematological MalignancyElderly PatientsMedicineAcute Myeloid LeukemiaIntermediate-dose CytarabinePharmacologyHematologyMixed-phenotype Acute LeukemiaPharmacotherapyOncologyMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1